Evaluation of the Diagnostic Capacity of a Smart Mattress Versus Conventional Polysomnography

This project corresponds to a descriptive, observational, and prospective study whose objective is to validate the functioning, accuracy, and clinical applicability of an intelligent mattress designed for the non-invasive detection of sleep-related respiratory disturbances, in comparison with level I polysomnography (the gold standard for OSA diagnosis). This phase constitutes the first stage of the global project aimed at the diagnosis and treatment of obstructive sleep apnea (OSA) through advanced monitoring and postural-adaptation technologies.

During the period between November 17, 2026, and March 1, 2028, all polysomnographies performed in the Sleep Unit of Hospital San Pedro will be incorporated into a systematic registry together with the data simultaneously generated by the intelligent mattress. The aim is to determine the level of agreement between both systems, validate the diagnostic utility of the mattress, and generate the database required for the subsequent development of artificial intelligence algorithms for the automatic identification of respiratory events and sleep stages.

1. REGISTRY PROCEDURES AND DATA QUALITY

The centralized registry will include all polysomnographic studies performed with Natus equipment, stored on its internal server, and the parallel recordings from the intelligent mattress. The registry structure will be designed to ensure data traceability, integrity, and quality, with specific procedures for technical validation, clinical verification, and coherence control.

1.1 Quality Assurance Plan

A quality assurance system will be established based on four pillars: 1. Initial technical validation

Each polysomnography will be reviewed by a sleep technician who will confirm: * Correct sensor placement. * Absence of recording failures. * Presence of at least 4 valid hours of sleep. * Adequate synchronization with the mattress. 2. Expert clinical review

A certified sleep-medicine specialist will manually score each PSG according to AASM 2022 recommendations, including: * Classification of apneas and hypopneas. * Detection of micro-arousals. * Analysis of sleep architecture. * Quantification of supine and non-supine time. * Determination of global AHI, supine AHI, and non-supine AHI. 3. Internal audit

Ten percent of the records will be reviewed by a second independent evaluator to estimate inter-observer agreement. Discrepancies \>10% in respiratory indices will trigger consensus sessions. 4. Mattress data integrity review

The system will automatically verify: * Temporal continuity of the recording. * Presence of stable BCG sensor signal. * Absence of failures in air chambers. * Integrity of the exported file.

1.2 Automated Data Checks

Mattress and PSG data will be subjected to validation through automated rules: * Range rules:

* Oxygen saturation between 50-100%. * Respiratory rate between 6-40 rpm. * Heart rate between 35-180 bpm. * Total sleep time between 2-12 h. * Internal coherence rules:

* Percentages of N1, N2, N3, and REM must sum ≤100%. * Number of events must be compatible with calculated AHI. * Time in bed must match total recording time. * Temporal consistency rules:

* Synchronization between PSG and mattress ±5 seconds.

Records generating alerts will be manually reviewed and classified as: * Valid. * Valid with warnings. * Unusable.

1.3 Source Data Verification (SDV)

A source-data verification process will be implemented, including: * Comparison of respiratory events detected by the mattress with those manually annotated in PSG. * Cross-checking of position (supine/non-supine) between both systems. * Verification of demographic variables against the clinical record. * Concordance of sleep time and arousals. 2. REGISTRY DATA DICTIONARY

The study will include a comprehensive data dictionary specifying: * Variable name. * Operational definition. * Unit of measurement. * Method of acquisition. * Source (PSG, mattress, or derived) * Standard coding (AASM 2022, MedDRA for events) * Expected physiological ranges.

Examples: * Global AHI: total number of apneas + hypopneas divided by sleep time in hours. * Micro-arousals: defined according to AASM as EEG frequency shifts ≥3 seconds. 3. STANDARD OPERATING PROCEDURES (SOPs)

The study includes documented SOPs for:

Installation, recording, and disconnection of PSG and mattress.

Manual scoring of respiratory and leg events.

Data export, anonymization, and archiving.

Synchronization and technical verification.

Data inconsistency management and queries.

Quality control and internal auditing.

Classification of incomplete records.

Security, privacy, and GDPR compliance.

Each SOP specifies responsibilities, operational steps, acceptance criteria, and incident-handling mechanisms. 4. SAMPLE SIZE ASSESSMENT

The planned sample size is 500 complete records. This calculation is based on:

\- An estimated accessible population of \~700 PSGs in the reference period.

\- A 95% confidence level. * A 1% margin of error. * The need for high statistical power for concordance comparisons. * Requirements for training AI models with a significant volume of observations. 5. MISSING DATA MANAGEMENT PLAN

Missing data will be classified as:

• Technical missing: signal loss, sensor failures.

• Poor-quality missing: valid time \<4h.

• Inconsistency missing: impossible ranges or temporal discrepancies.

• Administrative missing: export errors.

Criteria:

\- Exclusion of records with valid time \<4h. * Simple imputation for position data when outcomes are unaffected. * Multiple imputation only for AI model training. * Documentation of missing-data reasons in the incident log. 6. STATISTICAL ANALYSIS PLAN

• Total sleep time [Срок оценки: Night of simultaneous PSG and mattress recording (one night per participant).]
• Diagnostic accuracy according to sleep position. [Срок оценки: Night of simultaneous PSG and mattress recording (one night per participant).]
• Diagnostic accuracy by age group. [Срок оценки: Night of simultaneous PSG and mattress recording (one night per participant).]
• Subjective sleep quality (GSQS-8). [Срок оценки: Night of simultaneous PSG and mattress recording (one night per participant).]
• Descriptive demographic data. [Срок оценки: Night of simultaneous PSG and mattress recording (one night per participant).]
• Sleep efficiency [Срок оценки: Night of simultaneous PSG and mattress recording]
• Sleep stage [Срок оценки: Night of simultaneous PSG and mattress recording]
• detections of microarousals [Срок оценки: Night of simultaneous PSG and mattress recording]